CW October 2000
Volume 9Issue Number 10 October 2000 ISSN 10593802 Preventing Breast Cancer with Tamoxifen: Back to Square One (Again)?This year, the title of the Strang Award lecture states that "?the beginning of the end of breast cancer" is achievable with antiestrogens. Enthusiasm is laudable, but certainty is even better. Oncology is littered with debris, left behind by false interpretations. Some of this has been reflected in the many brief notes, published throughout the years in CW, which can pride itself of remaining critical and unbiased.
Go to Previous Page Go to Next Page Source & Additional Reading J. Norsigian et al., Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer. (J. Natl. Cancer Inst. 92, 757-758, 2000). Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
